Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma
Author(s) -
Peter Johnson,
Massimo Federico,
Amy A. Kirkwood,
Alexander Fosså,
Leanne Berkahn,
Angelo Michele Carella,
Francesco d’Amore,
Gunilla Enblad,
Antonella Franceschetto,
Michael Fulham,
Stefano Luminari,
Michael O'Doherty,
Pip Patrick,
Thomas A. Roberts,
Gamal Sidra,
Lindsey Stevens,
Paul Smith,
Judith Trotman,
Zaid Viney,
John Radford,
Sally F. Barrington
Publication year - 2016
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1510093
Subject(s) - abvd , medicine , procarbazine , dacarbazine , vinblastine , vincristine , nuclear medicine , bleomycin , hodgkin's lymphoma , radiology , lymphoma , chemotherapy , cyclophosphamide
We tested interim positron-emission tomography-computed tomography (PET-CT) as a measure of early response to chemotherapy in order to guide treatment for patients with advanced Hodgkin's lymphoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom